查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1683443

聚合物輔料：市場佔有率分析、產業趨勢與統計、成長預測（2025-2030 年）

Polymer Excipients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計預測期內聚合物輔料市場複合年成長率將超過 6%。

聚合物輔料-市場-IMG1

主要亮點

  • 隨著全球生物製藥趨勢的成長，預計市場將面臨各種成長機會。
  • 根據產品類型，聚乙烯吡咯烷酮（聚維酮）預計將佔據市場主導地位，因為其多功能性導致需求不斷增加。
  • 歐洲地區在全球聚合物輔料市場佔據主導地位，其中消費量最高的國家為德國、英國和法國。

聚合物輔料市場趨勢

聚乙烯吡咯烷酮（聚維酮）的需求不斷增加

  • 聚合物輔料是與活性藥物成分一起配製的物質。它們由天然存在的聚合物化合物（例如明膠）、半合成化合物（例如纖維素衍生物）和合成化合物（例如聚乙二醇）組成。
  • 聚乙烯吡咯烷酮具有獨特的易被人體吸收的特性，因此，預計預測期內製藥業對聚乙烯吡咯烷酮的需求增加將推動聚合物輔料市場的發展。
  • 此外聚乙烯吡咯烷酮還具有溶解性高、成膜性優良、生理不滲透性等優良性能。由於這些特性，它被廣泛用於錠劑、膠囊、口服液、滅菌劑和注射劑的生產。預計這些因素將在預測期內推動需求，刺激聚合物輔料市場。
  • 預測期內，全球聚乙烯吡咯烷酮（聚維酮）市場預計將以超過 8% 的複合年成長率成長。預計這將對預測期內聚合物輔料市場的成長產生正面影響。
  • 由於上述因素，預計預測期內聚合物輔料市場將快速成長。

歐洲主導市場

  • 預計預測期內歐洲將主導聚合物輔料市場。由於製藥業的不斷發展和人口老化，英國、德國和法國等國家對聚合物輔料的需求正在增加，此外，粘合劑、被覆劑、調味劑、防腐劑和甜味劑等各種應用的需求也在增加。
  • 口服固態劑型（OSDF）中輔料的使用不斷增加、研發不斷增加以及醫療保健基礎設施不斷改善，正在推動該地區藥品中聚合物輔料的消費。
  • 此外，聚合物賦形劑被用作治療藥物中活性成分的粘合劑，以促進其吸收。聚合物輔料是惰性劑，對藥物不起任何治療效果。它還有助於維持治療藥物的劑量、平衡和有效傳遞。這些因素增加了對聚合物賦形劑的需求，預計將在預測期內推動市場發展。
  • 預計預測期內歐洲醫藥市場將以超過 4% 的複合年成長率成長，到 2027 年市場價值將達到 2,200 億美元。這很可能為預測期內的聚合物輔料市場提供有利的機會。
  • 在歐洲地區企業發展的主要企業包括BASF公司、陶氏化學公司和贏創工業集團。
  • 上述因素加上政府的支持，將導致預測期內對聚合物輔料的需求增加。

聚合物輔料產業概況

聚合物輔料市場較為分散，主要企業僅佔有少量佔有率。市場的主要企業包括嘉吉公司、陶氏化學、贏創工業股份公司、ABITEC 和BASFSE。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 調查前提條件
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 驅動程式
    • 製藥業的成長
    • 塗層應用對聚合物輔料的需求不斷增加
  • 限制因素
    • 監管機構的嚴格監管
    • 對所需產品品質的擔憂
  • 產業價值鏈分析
  • 波特五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第5章 市場區隔

  • 產品類型
    • 聚乙烯吡咯烷酮
    • 聚乙二醇
    • 澱粉
    • 結晶纖維素（MCC）
    • 乙基纖維素和甲基纖維素
    • 羥丙基甲基纖維素 (HPMC)
    • 其他
  • 應用
    • 粘合劑
    • 黏度調節劑
    • 被覆劑
    • 香水
    • 防腐劑
    • 色素
    • 甜味劑
    • 其他
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 義大利
      • 法國
      • 其他歐洲國家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區
    • 中東和非洲
      • 沙烏地阿拉伯
      • 南非
      • 其他中東和非洲地區

第6章 競爭格局

  • 併購、合資、合作與協議
  • 市場佔有率（%）/排名分析
  • 主要企業策略
  • 公司簡介
    • ABITEC
    • ADM
    • Ashland
    • BASF SE
    • Cargill, Incorporated.
    • Colorcon
    • Croda International Plc
    • DFE Pharma
    • Dow
    • DuPont
    • Eastman Chemical Company
    • Evonik Industries AG
    • FINAR LIMITED
    • JRS PHARMA
    • Kerry Inc.
    • Roquette Freres
    • The Lubrizol Corporation

第7章 市場機會與未來趨勢

  • 全球生物製藥的擴張趨勢
  • 其他機會
簡介目錄
Product Code: 70898

The Polymer Excipients Market is expected to register a CAGR of greater than 6% during the forecast period.

Polymer Excipients - Market - IMG1

Key Highlights

  • Rising trend for biopharmaceuticals across the globe is expected to offer various lucrative opportunities for the growth of market.
  • By product type, polyvinylpyrrolidone (povidone) segment is expected to dominate the market owing to the increase in the demand due to its multifunctional abilities.
  • Europe region dominated the polymer excipients market across the globe with the largest consumption from countries such as Germany, United Kingdom, and France.

Polymer Excipients Market Trends

Increasing Demand for Polyvinylpyrrolidone (Povidone)

  • Polymer excipients are the substances which are formulated alongside the active ingredient of a medication. They consist of macromolecular compounds of natural origin such as gelatin, semisynthetic compounds such as cellulose derivatives, and synthetic compounds such as polyethylene glycols.
  • The increasing demand of polyvinylpyrrolidone in the pharmaceutical industry owing to its unique ability to get readily absorbed in the body is expected to propel the polymer excipients market during the forecast period.
  • Additionally, polyvinylpyrrolidone has superior properties such as good solubility, superb film forming, and physiological impermissibility. Owing to these properties, it is widely used in manufacturing tablets, capsules, oral liquids, sterilization disinfectant, and injection. Due to these factors, its demand is expected to increase during the forecast period, which would stimulate the polymer excipients market.
  • The global polyvinylpyrrolidone (povidone) market is expected to grow at a CAGR of over 8% during the forecast period. This is anticipated to positively impact the growth of polymer excipients market during the forecast period.
  • Owing to all the above-mentioned factors for polymer excipients, its market is expected to grow rapidly over the forecast period.

Europe Region to Dominate the Market

  • Europe region is expected to dominate the market for polymer excipients during the forecast period. In countries like United Kingdom, Germany, and France, owing to increasing demand from various applications such as binders, coating agents, flavors, preservatives, and sweeteners coupled with growing pharmaceutical industry in the region and growing old age population, the demand for polymer excipients has been increasing in the region.
  • The increased utilization of excipients in oral solid dosage form (OSDF) along with increased R&D and improved medical infrastructure has led to an increased consumption of polymer excipients in pharmaceutical drugs in the region.
  • Additionally, polymer excipients are used as binders for active ingredients in therapeutic drugs so that the active ingredients can be absorbed easily. They are inactive agents and do not have any therapeutic effect on the medicine. Also, they help in maintaining the dosage, balance and efficient delivery of the therapeutic drug. Due to these factors, the demand of polymer excipients is increasing, which expected to stimulate its market during the forecast period.
  • The Europe pharmaceuticals drugs market is expected to grow at a CAGR of over 4% during the forecast period and is expected to reach a market value of USD 220 billion by 2027. This is likely to provide lucrative opportunities for the polymer excipients market during the forecast period.
  • Some of the major companies operating in Europe region are - BASF SE, Dow, and Evonik Industries AG.
  • The aforementioned factors, coupled with government support, are contributing to the increasing demand forpolymer excipients during the forecast period.

Polymer Excipients Industry Overview

The Polymer Excipients market is fragmented with top players accounting for a marginal share of the market. Some of the key companies in the market include Cargill, Incorporated, Dow, Evonik Industries AG, ABITEC, and BASF SE.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Pharmaceutical Industry
    • 4.1.2 Rising Demand for Polymer Excipients from Coatings Application
  • 4.2 Restraints
    • 4.2.1 Stringent Rules by Regulatory Bodies
    • 4.2.2 Concerns to Meet the Required Quality of Product
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porters Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 Polyvinylpyrrolidone
    • 5.1.2 Polyethylene Glycol
    • 5.1.3 Starch
    • 5.1.4 Micro Crystalline Cellulose (MCC)
    • 5.1.5 Ethyl and Methyl Cellulose
    • 5.1.6 Hydroxypropyl Methylcellulose (HPMC)
    • 5.1.7 Others
  • 5.2 Application
    • 5.2.1 Binders
    • 5.2.2 Viscosity Modifiers
    • 5.2.3 Coatings
    • 5.2.4 Flavors
    • 5.2.5 Preservatives
    • 5.2.6 Colorants
    • 5.2.7 Sweeteners
    • 5.2.8 Others
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%)/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 ABITEC
    • 6.4.2 ADM
    • 6.4.3 Ashland
    • 6.4.4 BASF SE
    • 6.4.5 Cargill, Incorporated.
    • 6.4.6 Colorcon
    • 6.4.7 Croda International Plc
    • 6.4.8 DFE Pharma
    • 6.4.9 Dow
    • 6.4.10 DuPont
    • 6.4.11 Eastman Chemical Company
    • 6.4.12 Evonik Industries AG
    • 6.4.13 FINAR LIMITED
    • 6.4.14 JRS PHARMA
    • 6.4.15 Kerry Inc.
    • 6.4.16 Roquette Freres
    • 6.4.17 The Lubrizol Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Growing Trend of Biopharmaceuticals Across the Globe
  • 7.2 Other Opportunities